Zeteo Secures U.S. and EU Patents for Drug Delivery

Zeteo Biomedical has announced the issuance of two new patents—one in the United States and one in the European Union—for its proprietary drug delivery technology portfolio, ZTech. These patents further advance Zeteo’s development of compact, user-friendly drug/device combination systems designed for a variety of therapeutic applications, including ophthalmic use.

Overview of Recent Patent Approvals for ZTech Platform

The new patents include:

• US Patent No. 12329949: Cartridge Devices for Administration of a Medicament

• EU Patent No. 3946526: Hand-Operated Device for Administration of a Medicament

These patents enhance the protection and capabilities of Zeteo’s ZTech-L and ZTech-P platforms, which include both single-use disposable and multi-dose, cartridge-reloadable handheld delivery systems.

Expanding Applications: Ophthalmic, Nasal, and Sublingual Delivery

Zeteo’s technologies support the delivery of liquid and dry powder formulations, including biologics, specialty drugs, and vaccines. According to the company, these platforms are particularly suited for nasal, ophthalmic, and sublingual drug administration, offering a non-invasive, self-administered alternative for conditions such as:

• Pain management

• Seizures and emesis

• Neurodegenerative and autoimmune diseases

• Infectious diseases and bioterror threats

Device Versatility Across Varied Use Environments

A standout feature of Zeteo’s devices is their ability to function in any physical orientation, making them well-suited for use in space-based microgravity environments. This technology unlocks opportunities for space medicine applications, in addition to conventional terrestrial healthcare settings.

“We are seeing increasing global demand for metered-dose nasal, ophthalmic, and sublingual delivery devices that are compact, intuitive, and suitable for self-administration,” said Timothy Sullivan, CEO of Zeteo Biomedical. “Our technology’s reliability in any orientation opens exciting new frontiers, including applications in space-based healthcare.”